JNJ Sale Disclosure
Taubert Jennifer L · SEC Form 4 · Filed Aug 18, 2026
Sale
Calculated transaction value
$3.95M
Taubert Jennifer L EVP, Wwc. Innovative Medicine
JNJ
Transaction date
Aug 17, 2026
Public filing date
Aug 18, 2026
Filing lag
Filed 1 day later
JNJ daily price context
Close on/before transaction
$262.37
Aug 17, 2026
Close before public filing
$262.37
Aug 17, 2026
Return since public filing
+2.91%
Through Sep 18, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 15,000 shares @ $263.36
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0000200406-26-000175
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$5.69M
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Johnson & Johnson JNJ | Exercise | Aug 17, 2026 | $0 |
| Johnson & Johnson JNJ | Exercise | Aug 17, 2026 | $1.74M |
| Johnson & Johnson JNJ Current | Sale | Aug 17, 2026 | $3.95M |